PEROZIN ApS: Financial statements 2014
CVR: 29183910
Source: annual report 2014, Danish Business Authority
01/05/2013 – 30/04/2014
PEROZIN ApS (CVR 29183910) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 212,375 and a net result of DKK 169,250 compared with DKK 165,364 the year before. That is an increase of 29.5% compared with the year before. Equity in the 2014 report amounted to DKK 478,784. The solvency ratio was 80.7%.
- Gross Profit
- DKK 212,375
- Profit/Loss
- DKK 169,250
- Equity
- DKK 478,784
- Total Assets
- DKK 592,941
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 212 t. | 169 t. | 479 t. | - |
| 2013 | - | 164 t. | 165 t. | 310 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout PEROZIN ApS
PEROZIN ApS is a Danish company of the type Anpartsselskab based in Haslev, founded in 2005. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Gerard Gerner Hansen. The company is owned by GEBAL Holding ApS, Barghoth Ala Hasan Ali and Ehsan Ahmed Mousa Abdalla Elfarra. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 2,799,719 and a net result of DKK 1,026,124 compared with DKK 736,080 the year before. Equity in the 2025 report amounted to DKK 9,644,024.